rs143478074

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001199753.2(CPT1C):​c.1915G>A​(p.Ala639Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00323 in 1,613,954 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0022 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0033 ( 9 hom. )

Consequence

CPT1C
NM_001199753.2 missense

Scores

19

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.145

Publications

7 publications found
Variant links:
Genes affected
CPT1C (HGNC:18540): (carnitine palmitoyltransferase 1C) This gene encodes a member of the carnitine/choline acetyltransferase family. The encoded protein regulates the beta-oxidation and transport of long-chain fatty acids into mitochondria, and may play a role in the regulation of feeding behavior and whole-body energy homeostasis. Alternatively spliced transcript variants encoding multiple protein isoforms have been observed for this gene. [provided by RefSeq, Dec 2010]
CPT1C Gene-Disease associations (from GenCC):
  • hereditary spastic paraplegia 73
    Inheritance: AD Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • hereditary spastic paraplegia
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0077616274).
BP6
Variant 19-49711857-G-A is Benign according to our data. Variant chr19-49711857-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 476174.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00215 (328/152346) while in subpopulation NFE AF = 0.00351 (239/68036). AF 95% confidence interval is 0.00315. There are 1 homozygotes in GnomAd4. There are 160 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 328 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CPT1CNM_001199753.2 linkc.1915G>A p.Ala639Thr missense_variant Exon 17 of 20 ENST00000598293.6 NP_001186682.1 Q8TCG5-1A0A024QZE3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CPT1CENST00000598293.6 linkc.1915G>A p.Ala639Thr missense_variant Exon 17 of 20 2 NM_001199753.2 ENSP00000473028.1 Q8TCG5-1

Frequencies

GnomAD3 genomes
AF:
0.00215
AC:
328
AN:
152228
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000555
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00157
Gnomad ASJ
AF:
0.000864
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00348
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00351
Gnomad OTH
AF:
0.000955
GnomAD2 exomes
AF:
0.00238
AC:
598
AN:
251060
AF XY:
0.00228
show subpopulations
Gnomad AFR exome
AF:
0.000492
Gnomad AMR exome
AF:
0.000925
Gnomad ASJ exome
AF:
0.000993
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00461
Gnomad NFE exome
AF:
0.00380
Gnomad OTH exome
AF:
0.00163
GnomAD4 exome
AF:
0.00334
AC:
4882
AN:
1461608
Hom.:
9
Cov.:
30
AF XY:
0.00324
AC XY:
2358
AN XY:
727130
show subpopulations
African (AFR)
AF:
0.000418
AC:
14
AN:
33480
American (AMR)
AF:
0.000939
AC:
42
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00122
AC:
32
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.000220
AC:
19
AN:
86258
European-Finnish (FIN)
AF:
0.00412
AC:
219
AN:
53156
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
0.00391
AC:
4349
AN:
1111996
Other (OTH)
AF:
0.00341
AC:
206
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
276
552
828
1104
1380
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
154
308
462
616
770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00215
AC:
328
AN:
152346
Hom.:
1
Cov.:
32
AF XY:
0.00215
AC XY:
160
AN XY:
74512
show subpopulations
African (AFR)
AF:
0.000553
AC:
23
AN:
41586
American (AMR)
AF:
0.00157
AC:
24
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.000864
AC:
3
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00348
AC:
37
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00351
AC:
239
AN:
68036
Other (OTH)
AF:
0.000945
AC:
2
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
17
34
52
69
86
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00303
Hom.:
3
Bravo
AF:
0.00229
TwinsUK
AF:
0.00270
AC:
10
ALSPAC
AF:
0.00259
AC:
10
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00233
AC:
20
ExAC
AF:
0.00263
AC:
319
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Sep 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CPT1C: BS1, BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

CPT1C-related disorder Benign:1
Jun 30, 2020
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Hereditary spastic paraplegia 73 Benign:1
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.068
BayesDel_addAF
Benign
-0.36
T
BayesDel_noAF
Benign
-0.29
CADD
Benign
17
DANN
Benign
0.96
DEOGEN2
Benign
0.22
T;T;T;.
Eigen
Benign
-0.67
Eigen_PC
Benign
-0.56
FATHMM_MKL
Benign
0.16
N
LIST_S2
Benign
0.50
.;.;T;T
M_CAP
Benign
0.029
D
MetaRNN
Benign
0.0078
T;T;T;T
MetaSVM
Benign
-0.76
T
MutationAssessor
Benign
1.3
L;L;L;.
PhyloP100
0.14
PrimateAI
Benign
0.32
T
PROVEAN
Benign
-0.11
N;N;.;N
REVEL
Benign
0.18
Sift
Benign
0.57
T;T;.;T
Sift4G
Benign
0.60
T;T;T;T
Polyphen
0.0010
B;B;B;B
Vest4
0.25
MVP
0.68
MPC
0.85
ClinPred
0.018
T
GERP RS
2.3
Varity_R
0.026
gMVP
0.16
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143478074; hg19: chr19-50215114; COSMIC: COSV106097203; COSMIC: COSV106097203; API